Immunomodulatory Effects of Dopamine in Inflammatory Diseases
Dopamine (DA) receptor, a significant G protein-coupled receptor, is classified into two families: D1-like (D1 and D5) and D2-like (D2, D3, and D4) receptor families, with further formation of homodimers, heteromers, and receptor mosaic. Increasing evidence suggests that the immune system can be aff...
Main Authors: | Yifei Feng, Yan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.663102/full |
Similar Items
-
Ferroptosis and Autoimmune Diseases
by: Benjamin Lai, et al.
Published: (2022-06-01) -
Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases
by: Fangfang Huang, et al.
Published: (2022-01-01) -
The SYSCID map: a graphical and computational resource of molecular mechanisms across rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease
by: Marcio Luis Acencio, et al.
Published: (2023-11-01) -
Editorial: Recent Advances in Potential Biomarkers for Rheumatic Diseases and in Cell-Based Therapies in the Management of Inflammatory Rheumatic Diseases
by: Philippe Saas, et al.
Published: (2022-01-01) -
No causal association between pneumoconiosis and three inflammatory immune diseases: a Mendelian randomization study
by: Yu-Jie Du, et al.
Published: (2024-03-01)